跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
6% Dextran 70 in 0.9% Sodium chloride 500mL injection FKB5013G - TGA Drug Approval Details
Approvals
/
TGA
/
6% Dextran 70 in 0.9% Sodium chloride 500mL injection FKB5013G
Approved
STANDARD
6% Dextran 70 in 0.9% Sodium chloride 500mL injection FKB5013G
Baxter Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
7c6e5dbbef611cda
Company
Baxter Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
7c6e5dbbef611cda
Product Name
6% Dextran 70 in 0.9% Sodium chloride 500mL injection FKB5013G
Artg Id
19429
Artg Name
6% DEXTRAN 70 in 0.9% SODIUM CHLORIDE 500mL injection bag FKB5013G
Sponsor
Baxter Healthcare Pty Ltd
Company Detail Path
/organization/baxter-healthcare-pty-ltd
Artg Date
1991-09-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
7c6e5dbbef611cda
Type
Standard
Back to TGA Approvals